GG
VXRT

Gofen & Glossberg’s Vaxart VXRT Stock Holding History

Gofen & Glossberg’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$18K Hold
18,325
– – ﹤0.01% 569
2022
Q3 		$40K Sell
18,325
-253
-1% -$872 ﹤0.01% 536
2022
Q2 		$65K Buy
+18,578
New +$69.4K ﹤0.01% 533

Other funds holding VXRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gofen & Glossberg's VXRT Position: Q4 2022 in Review

Gofen & Glossberg held its Vaxart (VXRT) position steady in Q4 2022 at 18,325 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Gofen & Glossberg first reported a position in VXRT in Q2 2022 and has held it in 3 quarters since. The position peaked at $65K in Q2 2022. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • Gofen & Glossberg held 18,325 shares of Vaxart worth $18K as of Q4 2022.
  • Gofen & Glossberg left its Vaxart share count unchanged in Q4 2022.
  • Vaxart made up ﹤0.01% of Gofen & Glossberg's portfolio in Q4 2022, its #569 holding.
  • Gofen & Glossberg first reported a position in Vaxart in Q2 2022 and has held it in 3 quarters since.
  • Gofen & Glossberg's Vaxart position peaked at $65K in Q2 2022.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.